Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosuvastatin Use in Order to Induce Preeclampsia Resolution in Severe Preeclampsia Cases up to 48 Hours Following Delivery

NCT02314286 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT02314286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02314286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosuvastatin Use in Order to Induce Preeclampsia Resolution in Severe Preeclampsia Cases up to 48 Hours Following Delivery
Lead sponsor
Soroka University Medical Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 31, 2014
Completion date
July 31, 2016
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe pre-eclampsia